Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation

PHASE4CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 2, 2018

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions

Suicidal Ideation

Interventions

DRUG

Uridine

Uridine is the active treatment in this clinical trial.

DRUG

Placebo

Pill placebo is the inactive treatment comparator in this clinical trial.

Trial Locations (1)

VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City

All Listed Sponsors

lead

VA Office of Research and Development

FED

NCT03265964 - Clinical and Imaging Trial of Uridine for Veterans With Suicidal Ideation | Biotech Hunter | Biotech Hunter